--- title: "92 Biotech Investors in the UK (Nov 2026): Top 10 Ranked" last_updated: "2026-11-05" rows: "92" free_rows: "25" source: "SEC Form D filings and our own research" canonical: "https://theinvestordatabase.com/lists/biotech-investors-uk/" --- # 92 biotech investors in the UK We list 92 biotech investors in the UK as of November 2026: 2 have an SEC filing on file and 90 were checked on the firm's own website or an official register, and the list was last checked on 5 Nov 2026. The cities with the most head offices on this list are London (40), Cambridge (8) and Edinburgh (4). - 92 investors - 38 with a fund filing or dated deal in the last 12 months - 494 named decision-makers on file ## First 25 of 92 biotech investors in the UK | Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile | |---|---|---|---|---|---|---|---|---| | BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ | | Start Codon | Accelerator | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI | Portfolio news, Nov 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/start-codon/ | | Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-innovation-capital/ | | Epidarex Capital | VC firm | Edinburgh, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Jul 2026 | $17M (SEC Form ADV) | 2026-11-04 | https://theinvestordatabase.com/investors/epidarex-capital/ | | Highland Europe | VC firm | London, United Kingdom | Growth | Biotech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/highland-europe/ | | Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Biotech, Healthtech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/claret-capital-partners/ | | Archangels | Angel network | Edinburgh, United Kingdom | Pre-seed, Seed, Series A, Growth | Biotech, Media, Deep Tech, Healthtech | Portfolio news, Nov 2026 | £10M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/archangels/ | | LYVA Labs | Government or university fund | Liverpool, United Kingdom | Pre-seed | Biotech, AI, Healthtech, Climate Tech | Portfolio news, Oct 2026 | £7M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/lyva-labs/ | | Cambridge Capital Group | Angel network | Cambridge, United Kingdom | Seed, Growth | Biotech, Industrial Tech, AI, Developer Tools | New fund, Oct 2026 | £50M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-capital-group/ | | Outlier Ventures | VC firm | United Kingdom | Pre-seed, Seed, Series A, Growth | Biotech, AI, Robotics, Fintech | New deal, Oct 2026 | $500M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/outlier-ventures/ | | Gabriel Investment Syndicate | Angel network | United Kingdom | Pre-seed, Seed | Biotech, Healthtech, Generalist, Deep Tech | Portfolio news, Oct 2026 | £4M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/gabriel-investment-syndicate/ | | Equity Gap | Angel network | Edinburgh, United Kingdom | Seed | Biotech, Healthtech, Climate Tech, SaaS | Portfolio news, Jul 2026 | £70M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/equity-gap/ | | Empirical Ventures | SEIS/EIS fund | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Semiconductor, Deep Tech | New deal, Jul 2026 | £50M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/empirical-ventures/ | | Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Biotech, Healthtech, Deep Tech, AI | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-angels/ | | UKI2S | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jul 2025 | £150M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/uki2s/ | | Kelvin Capital | Angel network | Glasgow, United Kingdom | Seed, Growth | Biotech, Generalist, Agritech, Climate Tech | New fund, Mar 2026 | £150M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/kelvin-capital/ | | Advent Life Sciences | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | New fund, May 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/advent-life-sciences/ | | Martlet Capital | VC firm | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jun 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/martlet-capital/ | | Eos Advisory | Angel network | St Andrews, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, Robotics, AI | Portfolio news, Mar 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/eos-advisory/ | | Catapult Ventures | Fund manager | Spalding, United Kingdom | Seed, Growth | Biotech, AI, Robotics, Fintech | Portfolio news, Apr 2026 | $80M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/catapult-ventures/ | | Elbow Beach | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Climate Tech, Agritech | New deal, Oct 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/elbow-beach/ | | o2h Ventures | SEIS/EIS fund | Cambridge, United Kingdom | Seed, Growth | Biotech, Healthtech, AI, Deep Tech | New deal, Nov 2025 | £8M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/o2h-ventures/ | | Calculus Capital | SEIS/EIS fund | London, United Kingdom | Growth | Biotech, Fintech, SaaS, Healthtech | Portfolio news, Jun 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/calculus-capital/ | | Cambridge Enterprise | Government or university fund | Cambridge, United Kingdom | | Biotech, AI, Industrial Tech, Deep Tech | Portfolio news, Oct 2026 | | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-enterprise/ | | Oxford Science Enterprises | VC firm | Oxford, United Kingdom | Pre-seed, Seed, Series A, Series B, Growth | Biotech, Healthtech, AI, Deep Tech | Portfolio news, Mar 2026 | £1.4B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/oxford-science-enterprises/ | You are seeing 25 of 92. The full list adds 67 more investors and 494 named decision-makers. Get all 92 investors and 494 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-uk This page: https://theinvestordatabase.com/lists/biotech-investors-uk/ ## Method and limits - Source: 2 of the 92 rows carry an SEC filing (Form D or Form ADV). All 92 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research. - Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. - Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. - Fill rates: Of 92 rows: stage 88, sector 92, fund size 33, website 92. In the paid file: named decision-makers on 81 rows, firm email on 62, LinkedIn page on 73, check size on 46. ## Questions ### How many biotech investors in the UK are there? We list 92 as of November 2026. 38 of the 92 have a fund filing or a dated deal in the last 12 months. The cities with the most are London (40), Cambridge (8) and Edinburgh (4). ### Which biotech investors in the UK raised a new fund in the last 12 months? 3 of the 92 have a fund filing dated in the last 12 months. The most recent on this list are Highland Europe (Jul 2026), ET Capital (Apr 2026) and Medicxi (Nov 2025). ### What is the typical fund size of biotech investors in the UK? Too few firms on this list disclose a fund size on an SEC Form D to give a median (1 of 92). 32 rows carry a size or assets figure from another public source, for example BGF at £3.0B (own site) and Cambridge Innovation Capital at £600M (own site). ### Which stage do most biotech investors in the UK back? Of the 88 with a stage on file, seed (75), pre-seed (41) and Series A (38). A firm can back more than one stage, and 4 rows have no stage on file yet. ### Where does the data on biotech investors in the UK come from and how often is it updated? 2 of the 92 rows have an SEC filing on file (Form D or Form ADV) and 90 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 5 Nov 2026 at the latest. The whole file is re-verified twice a year. ### Can I download the list of biotech investors in the UK as a spreadsheet? Yes. The file holds all 92 rows in Excel and CSV, with 494 named decision-makers and 62 firm emails, for $49 one-time. 25 rows are free on this page.